Abbott (ABT) Tops Q2 EPS by 3c; offers guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $116.64 +2.19%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q2 EPS of $1.31, $0.03 better than the analyst estimate of $1.28. Revenue for the quarter came in at $12.59 billion versus the consensus estimate of $12.52 billion.
GUIDANCE:
Abbott sees FY2026 EPS of $5.45-$5.60, versus the consensus of $5.48.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
- HSBC Downgrades Kakao Corp. (035720:KS) to Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
